P. Thakur et al. / Tetrahedron: Asymmetry 23 (2012) 659–661
661
concentrated under reduced pressure. The crude aldehyde was
used directly for the next reaction.
for 3 h and the solvent was removed under reduced pressure, the
obtained crude residue was dissolved in 2 ml MeOH, and TsOH
(3.9 mg, 0.02 mmol) was added and stirred overnight at rt. The sol-
vent was removed under reduced pressure. The crude residue was
subjected to column chromatography on silica gel (hexane/AcOEt
6:4) to afford goniothalesdiol A (51 mg, 86%) as white solid. Mp
To a pre-cooled (ꢀ78 °C) stirred solution of the PhMgBr [pre-
pared from PhBr (1.2 mL, 11.6 mmol) and Mg (348 mg, 14.5 mmol)
in anhydrous ether (20 mL) at room temperature], the above pre-
pared aldehyde was added dropwise in anhydrous ether (10 mL),
and the resulting mixture was stirred at the same temperature
for 6 h. The reaction was quenched with an aqueous saturated
ammonium chloride solution (10 mL), and the reaction mixture
was diluted with Et2O (15 mL). The organic layer was washed with
NH4Cl (aq) (30 mL), and dried over anhydrous Na2SO4 which upon
evaporation of the solvent, yielded a mixture of diastereomers,
which were carefully separated by column chromatography 230–
400 silica gel (ethylacetate/hexane 1:9) to afford 4a (0.20 g, 14%),
followed by pure major diastereomer 4 (0.90 g, 63%) as a colorless
oil. Rf = 0.4 (20% EtOAc/hexane).
91 °C (lit.5a mp 92 °C);
½
a 2D8
ꢂ
¼ ꢀ25:5 (c 1.2, CHCl3); Lit.5a
½
a 2D5
ꢂ
¼ ꢀ27:2 (c 0.3, CHCl3); IR (neat): 3425, 2924, 2856, 1732,
1441, 1168. 1H NMR (400 MHz; CDCl3): d 7.42–7.29 (m, 5H), 4.54
(d, J = 9.52 Hz, 1H), 4.43–4.33 (m, 1H), 4.23–4.17 (m, 1H), 3.65 (s,
3H), 3.49 (d, J = 9.5 Hz, 1H), 2.60 (dd, J = 15.4, 7.3 Hz, 1H), 2.44
(dd, J = 14.6, 5.7 Hz, 1H), 2.12–2.04 (m, 1H), 1.81 (br s, 1H), 1.78–
1.69 (m, 1H) 1.53 (br s, 1H). 13C NMR (100 MHz, CDCl3): d 171.3,
139.2, 128.4, 128.2, 127.3, 77.7, 72.6, 68.4, 67.0, 51.6, 40.3, 37.1.
HRMS (ESI): m/z [M+H]+ calcd for C14H19O5: 267.1232: found:
267.1224.
4.1.2.1. Analytical data for compound 4.
½
a 2D9
ꢂ
¼ ꢀ2:1 (c 0.3,
Acknowledgments
CHCl3); IR (KBr): 3448, 2933, 2984, 1641, 1454, 1380, 1219,
1058; 1H NMR (400 MHz; CDCl3): d 7.43–7.28 (m, 5H), 5.80–5.69
(m, 1H), 5.11–5.04 (m, 2H), 4.70 (d, J = 57 Hz, 1H), 4.35 (t,
J = 5.7 Hz, 1H), 4.21–4.15 (m, 1H), 2.85 (br s, 1H), 2.54–2.44 (m,
1H), 2.29–2.20 (m, 1H), 1.58 (s, 3H), 1.40 (s, 3H); 13C NMR
(100 MHz, CDCl3) d 140.6, 134.5, 128.6, 128.1, 127.3, 117.2,
108.4, 80.7, 76.7, 72.1, 34.3, 27.7, 25.2.
We are thankful to Dr. Reddy’s Laboratories Ltd for support and
Maithili Life Sciences Pvt. Ltd for financial assistance.
References
1. (a) Searle, P. A.; Molinski, T. F. J. Am. Chem. Soc. 1995, 117, 8126–8131; (b)
Schummer, D.; Gerth, K.; Reichenbach, H.; Hofle, G. Liebigs Ann. 1995, 685–688;
(c) Horton, P. A.; Koehn, F. E.; Longley, R. E.; McConnell, O. J. J. Am. Chem. Soc.
1994, 116, 6015–6016; (d) D’Ambrosio, M.; Guerriero, A.; Debitus, C.; Pietra, F.
Helv. Chim. Acta 1996, 79, 51–60; (e) Moore, R. E.; Patterson, G. M. L.; Mynderse,
J. S.; Barchi, J., Jr. Pure Appl. Chem. 1986, 58, 263–271; (f) Ishibashi, M.; Moore, R.
E.; Patterson, G. M. L.; Xu, C.; Clardy, J. J. Org. Chem. 1986, 51, 5300–5306; (g)
Carmely, S.; Kashman, Y. Tetrahedron Lett. 1985, 26, 511–514; (h) Jansen, R.;
Wray, V.; Irschik, H.; Reichenbach, H.; Hofle, G. Tetrahedron Lett. 1985, 26,
6031–6034; (i) Tanaka, J.; Higa, T.; Kobayashi, M.; Kitagawa, I. Chem. Pharm.
Bull. 1990, 38, 2967–2970; (j) Tanaka, J.; Higa, T. Tetrahedron Lett. 1996, 37,
5535–5538;.
2. (a) El-Zayat, A. A. E.; Ferringi, N. R.; McCloud, T. G.; McKenzie, A. T.; Byrn, S. R.;
Cassady, J. M.; Chang, C.-J.; McLaughlin, J. L. Tetrahedron Lett. 1987, 26, 955–
956; (b) Sam, T. W.; Chew, S. Y.; Matsjeh, S.; Gan, E. K.; Razak, D.; Mohamed, A.
L. Tetrahedron Lett. 1987, 28, 2541–2544; (c) Fang, X.-P.; Anderson, J. E.; Chang,
C.-J.; Fanwick, P. E.; McLaughlin, J. L. J. Chem. Soc., Perkin Trans. 1 1990, 1655–
1661; (d) Fang, X.-P.; Anderson, J. E.; Chang, C.-J.; Fanwick, P. E.; McLaughlin, J.
L. Tetrahedron 1991, 47, 9751–9758; (e) Fang, X.-P.; Anderson, J. E.; Qiu, X.-X.;
Kozlowski, J. F.; Chang, C.-J.; McLaughlin, J. L. Tetrahedron 1993, 49, 1563–1570.
3. (a) Gu, Z.-M.; Fang, X.-P.; Zeng, L.; McLaughlin, J. L. Tetrahedron Lett. 1994, 35,
5367–5368; (b) Fang, X.-P.; Anderson, J. E.; Smith, D. L.; Wood, K. V.;
McLaughlin, J. L. J. Nat. Prod. 1992, 55, 1655–1663.
4.1.2.2. Analytical data for compound 4a.
½
a 2D9
ꢂ
¼ ꢀ8:5 (c 0.3,
CHCl3); IR (KBr): 3411, 2925, 2854, 1641, 1600, 1494, 1452, 916,
700; 1H NMR (400 MHz; CDCl3): d 7.56–7.01 (m, 5H), 6.04–5.86
(m, 1H), 5.09 (ddd J = 15.9, 11.0, 1.3 Hz, 2H), 4.56 (d, J = 9.3 Hz,
1H), 3.91–3.83 (m, 1H), 3.27 (t, J = 9.3, Hz, 1H), 2.60–2.50 (m,
1H), 2.36–2.25 (m, 1H), 1.59 (s, 3H), 1.49 (s, 3H); 13C NMR
(100 MHz, CDCl3): d 143.7, 134.5, 128.4, 127.5, 126.5, 117.0,
108.4, 76.2, 72.8, 72.2, 36.8, 29.5, 19.4.
4.1.3. (E)-Methyl 4-{(4S,5R)-5-[(R)-hydroxy(phenyl)methyl]-2,2-
dimethyl-1,3-dioxolan-4-yl}but-2-enoate 3
Compound 4 (0.3 g, 1.2 mmol) and methyl acrylate (0.728 g,
8.5 mmol) were added via syringe to a stirring solution of Grubbs
2nd generation catalyst (50 mg, 0.05 mmol, 5.0 mol %) in dichloro-
methane (1.5 mL). The flask was capped with a rubber septum,
flushed with dry nitrogen, and stirred under nitrogen for 3 h at
rt. The reaction mixture was then reduced in volume to 0.5 mL
and purified directly by silica gel column chromatography (6%
EtOAc/hexane) to provide 3 (0.356 g, 97% yield) as a brown oil.
4. Lan, Y.-H.; Chang, F.-R.; Yang, Y.-L.; Wu, Y.-C. Chem. Pharm. Bull. 2006, 54, 1040–
1043.
5. (a) Yadav, J. S.; Rami Reddy, N.; Harikrishna, V.; Subba Reddy, B. V. Tetrahedron
Lett. 2009, 50, 1318–1320; (b) Yadav, J. S.; Nageshwar Rao, R.; Somaiah, R.;
Harikrishna, V.; Subba Reddy, B. V. Helv. Chim. Acta 2010, 93, 1362–1368; (c)
Venkataiah, M.; Somaiah, P.; Reddipalli, G.; Fadnavis, N. W. Tetrahedron:
Asymmetry. 2009, 20, 2230–2233; (d) Li, J.; Zheng, H.; Su, Y.; Xie, X.; She, X.
Synlett 2010, 2283–2284; (e) Sabitha, G.; Rammohan Reddy, T.; Yadav, J. S.
Tetrahedron Lett. 2011, 52, 6550–6553.
6. Jogireddy, R.; Dakas, P. Y.; Valot, G.; Barluenga, S.; Winssinger, N. Chem. Eur. J.
2009, 15, 11498–11506.
7. Geng, X.; Danishefsky, S. J. Org. Lett. 2004, 6, 413–416.
8. Kanger, T.; Niidas, P.; Müürisepp, A. M.; Pehk, T.; Lopp, M. Tetrahedron:
Asymmetry. 1998, 9, 2499–2508.
9. Chatterjee, A. K.; Choi, T.-L.; Sanders, D. P.; Grubbs, R. H. J. Am. Chem. Soc. 2003,
125, 11360–11370.
10. Paterson, I.; Anderson, E. A.; Dalby, S. M.; Genovino, J.; Lim, J. H.; Moessner, C.
Chem. Commun. 2007, 1852–1854.
Rf = 0.40 (50% EtOAc in hexane). ½a D28
¼ ꢀ87:2 (c 0.15, CHCl3); IR
ꢂ
(KBr): 3451, 2935, 2987, 1722, 1658, 1437, 1219, 1059; 1H NMR
(400 MHz; CDCl3): d 7.41–7.30 (m, 5H), 6.92–6.83 (m, 1H), 5.84
(dt, J = 15.9, 1.3 Hz, 1H), 4.67 (dd, J = 4.4, 1.3 Hz, 1H), 4.41 (t,
J = 6.2 Hz, 1H), 4.23–4.17 (m, 1H), 3.71 (, 3H), 2.79 (d, 1H), 2.67–
2.57 (m, 1H), 2.38–2.29 (m, 1H), 1.57 (s, 3H), 1.39 (s, 3H); 13C
NMR (100 MHz, CDCl3): d 166.6, 144.9, 140.1, 128.7, 128.4, 127.3,
123.1, 108.7, 80.6, 75.7, 75.2, 51.5, 33.0, 27.7, 25.2; (ESI-MS): m/z
307 (M+H+). HRMS: calcd for C17H22NaO5: 329.1364 (M+Na),
found: 329.1372.
4.1.4. Goniothalesdiol A 1
To compound 3 (69 mg, 0.2 mmol) in benzene (2 ml) was added
TsOH (3.9 mg, 0.02 mmol). The reaction mixture was stirred at rt